ARDX
Price
$3.68
Change
+$0.04 (+1.10%)
Updated
Jun 6 closing price
Capitalization
880.46M
52 days until earnings call
MYNDF
Price
$0.03
Change
+$0.02 (+200.00%)
Updated
May 20 closing price
Capitalization
2.45M
Interact to see
Advertisement

ARDX vs MYNDF

Header iconARDX vs MYNDF Comparison
Open Charts ARDX vs MYNDFBanner chart's image
Ardelyx
Price$3.68
Change+$0.04 (+1.10%)
Volume$6.93M
Capitalization880.46M
MYND Life Sciences
Price$0.03
Change+$0.02 (+200.00%)
Volume$200
Capitalization2.45M
ARDX vs MYNDF Comparison Chart
Loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARDX vs. MYNDF commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Buy and MYNDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ARDX: $3.91 vs. MYNDF: $0.03)
Brand notoriety: ARDX and MYNDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 57% vs. MYNDF: 1%
Market capitalization -- ARDX: $880.46M vs. MYNDF: $2.45M
ARDX [@Biotechnology] is valued at $880.46M. MYNDF’s [@Biotechnology] market capitalization is $2.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whileMYNDF’s FA Score has 1 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • MYNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, MYNDF is a better buy in the long-term than ARDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 5 TA indicator(s) are bullish.

  • ARDX’s TA Score: 5 bullish, 4 bearish.

Price Growth

ARDX (@Biotechnology) experienced а -2.01% price change this week, while MYNDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ARDX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARDX($880M) has a higher market cap than MYNDF($2.45M). ARDX YTD gains are higher at: -22.880 vs. MYNDF (-48.550).
ARDXMYNDFARDX / MYNDF
Capitalization880M2.45M35,962%
EBITDA-16.71MN/A-
Gain YTD-22.880-48.55047%
P/E RatioN/AN/A-
Revenue334MN/A-
Total Cash250MN/A-
Total Debt153MN/A-
FUNDAMENTALS RATINGS
ARDX: Fundamental Ratings
ARDX
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
46
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARDX
RSI
ODDS (%)
Bullish Trend 13 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 13 days ago
76%
Momentum
ODDS (%)
Bullish Trend 13 days ago
82%
MACD
ODDS (%)
Bullish Trend 13 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 13 days ago
82%
Advances
ODDS (%)
Bullish Trend 21 days ago
86%
Declines
ODDS (%)
Bearish Trend 19 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 13 days ago
89%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with HRTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
-1.51%
HRTX - ARDX
37%
Loosely correlated
-3.17%
RIGL - ARDX
37%
Loosely correlated
-2.19%
CSCI - ARDX
35%
Loosely correlated
+2.12%
PCVX - ARDX
34%
Loosely correlated
-1.10%
RNAC - ARDX
34%
Loosely correlated
+3.65%
More

MYNDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYNDF has been loosely correlated with ARDX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MYNDF jumps, then ARDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNDF
1D Price
Change %
MYNDF100%
N/A
ARDX - MYNDF
33%
Loosely correlated
-1.51%
AMLX - MYNDF
32%
Poorly correlated
+1.48%
RNAC - MYNDF
28%
Poorly correlated
+3.65%
TNYA - MYNDF
24%
Poorly correlated
-2.67%
ICCC - MYNDF
24%
Poorly correlated
N/A
More